Journal
MOLECULAR PHARMACEUTICS
Volume 10, Issue 11, Pages 4391-4395Publisher
AMER CHEMICAL SOC
DOI: 10.1021/mp400028m
Keywords
LCP; nanoparticle toxicity; intracellular calcium; calcium indicator
Funding
- NIH [CA129835, CA149363, CA151652]
Ask authors/readers for more resources
To address the question of how cells respond to the possible Ca2+ toxicity caused by the release of Ca2+ into the cytoplasm by LCP nanoparticles, a series of in vitro and in vivo studies using Ca2+ pump inhibitors were conducted. The results indicated that two major Ca2+ pumps on the plasma membrane and the mitochondrial membrane, respectively, were able to rapidly respond to the elevated cytosolic Ca2+ concentration and prevent Ca2+-induced apoptosis or necrosis. However, exposure to specific inhibitors of calcium pumps would cause LCP-treated H460 cells to undergo necrosis both in vitro and in vivo. These results demonstrated that the Ca2+ delivered by LCP was not toxic to cells when the cells contain functional Ca2+ pumps.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available